StockData
Renalytix plc logo

Renalytix plc (RNLXY) shareholders

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Ownership

Who owns Renalytix's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Icahn School Of Medicine At Mount Sinai (“ismms”)35,653,47710.68%13D (active) amendmentNov 1, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mount Sinai Hospitals Group, Inc.
10% owner
Nov 1, 2024Other+13,366,750$0.12$1.60M32,683,998
School Of Medicine At Mount Sinai Icahn
10% owner
Apr 24, 2024Other+9,360,374$0.25$2.34M19,317,248

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
2.8
At 0M shares a day
Change since last report
+3701.2%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Renalytix's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,987 shares on Sep 4, 2026 over the last 90 days.

See a number that looks wrong?